MLTX
MoonLake Immunotherapeutics
NASDAQ · Healthcare · Biotechnology · CH
$14.98
−1.38%Leverage
- Debt / equity
- 0.24x
- Net debt / equity
- -0.88x
- Debt / assets
- 0.18x
- Debt / EBITDA
- -0.40x
- Net debt / EBITDA
- 1.50x
Liquidity & coverage
- Current ratio
- 12.56x
- Quick ratio
- 12.56x
- Cash ratio
- 11.83x
- Interest coverage
- -26.58x
- EBITDA / interest
- -24.85x
- Working capital
- $524.6M
Cash & dividend
- FCF / debt
- -2.22x
- Cash flow / debt
- -2.22x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026